OCC1 Polyclonal Antibody
Product Specifications
Background
OCC1 was initially identified as a novel human cDNA overexpressed in a colon carcinoma cell line. Elevated levels of OCC1 mRNA were observed in three of eight colon carcinomas, suggesting that OCC1 may be a hallmark of only a subset of colon carcinomas. It is highly expressed in skeletal muscle, kidney, placenta, and pancreas tissues, with low to no expression in heart, brain, lung and liver tissues. At least two different OCC1 mRNA species are known to exist.
Synonyms
C12orf75; Chromosome 12 open reading frame 75; Hypothetical protein LOC387882; MGC148100; MGC149157; OCC 1; OCC-1; Putative overexpressed in colon carcinoma 1 protein; OCC1_HUMAN.
Cellular Locus
Cytoplasm
Host
Rabbit
Immunogen
21-63/63
Target
OCC1
Clonality
Polyclonal
Isotype
IgG
Conjugation
Unconjugated
Source
KLH conjugated synthetic peptide derived from human OCC1
Applications
ELISA, IHC-P, IHC-F, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Concentration
1µg/µl
Dilution
ELISA (1:500-1000), IHC-P (1:200-400), IHC-F (1:100-500), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Product Datasheet
https://www.biossantibodies.com/datasheets/bs-6556R
Predicted Cross Reactivity
Human
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items